AU Patent

AU2016328150B2 — Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof

Assigned to XWPharma Ltd · Expires 2020-10-01 · 6y expired

What this patent protects

Provided are prodrugs of gamma-hydroxybutyric acid as well as compositions and uses thereof.

USPTO Abstract

Provided are prodrugs of gamma-hydroxybutyric acid as well as compositions and uses thereof.

Drugs covered by this patent

sodium-oxybate (SODIUM OXYBATE)

Patent Metadata

Patent number: AU2016328150B2
Jurisdiction: AU
Classification: —
Expires: 2020-10-01
Drug substance claim: No
Drug product claim: No
Assignee: XWPharma Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.